413 related articles for article (PubMed ID: 28407747)
1. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
2. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
3. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
4. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
[TBL] [Abstract][Full Text] [Related]
5. Patterns of clozapine prescribing in a mental health service in New Zealand.
Harrison J; Janlöv M; Wheeler AJ
Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
7. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
8. POMHS 9b - antipsychotic prescribing in people with a learning disability.
Thalitaya MD; Udu V; Nicholls M; Clark T; Prasher VP
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S50-6. PubMed ID: 21894103
[TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
10. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales.
Patel MX; Bishara D; Jayakumar S; Zalewska K; Shiers D; Crawford MJ; Cooper SJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):499-509. PubMed ID: 24491953
[TBL] [Abstract][Full Text] [Related]
11. The use of atypical antipsychotics in French psychiatric hospitals.
Bret MC; Bret P; Pariente A; Fourier-Réglat A
Pharm World Sci; 2007 Oct; 29(5):551-6. PubMed ID: 17638111
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of High-dose Antipsychotic Prescribing in Schizophrenia: A Clinical Audit in a Regional Queensland Mental Health Service.
Luthra S; Duggan L; Agrawal A; Kaur G; Luthra N
Int J Appl Basic Med Res; 2023; 13(2):70-76. PubMed ID: 37614838
[TBL] [Abstract][Full Text] [Related]
13. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
[TBL] [Abstract][Full Text] [Related]
14. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
15. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic prescribing and its correlates in New Zealand.
Dey S; Menkes DB; Obertova Z; Chaudhuri S; Mellsop G
Australas Psychiatry; 2016 Aug; 24(4):360-4. PubMed ID: 26819405
[TBL] [Abstract][Full Text] [Related]
17. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
Taylor DM; Young C; Paton C
J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
[TBL] [Abstract][Full Text] [Related]
19. Clozapine prescribing in a Canadian outpatient population.
Alessi-Severini S; Le Dorze JA; Nguyen D; Honcharik P; Eleff M
PLoS One; 2013; 8(12):e83539. PubMed ID: 24358290
[TBL] [Abstract][Full Text] [Related]
20. Prescribing of antipsychotics in UK primary care: a cohort study.
Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
